维普期刊资源整合服务平台（V6.5）

49篇 您的检索式：作者名="Carew JS"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance显示文摘	Carew JS Nawrocki ST Kahue CN	2007	Blood2007，110，1：	1
2	Autophagy as a target for cancer therapy: new developments显示文摘	Carew JS Kelly KR Nawrocki ST	2012	Cancer Manag Res2012，4，：	1
3	After chemotherapy:clinical significance and therapeutic implications显示文摘	Carew JS Zhou Y Albitar M	2003	Leukemia2003，17，8：	1
4	Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation显示文摘	Carew JS	2009	Cell Mol2009，2，：	1
5	Mitochondrial defects in cancer 显示文摘	Carew JS Huang P	2002	Mol Cancer2002，1，：	1
6	Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance显示文摘	Carew JS Nawrocki ST Kahue CN	2007	Blood2007，110，1：	1
7	Bortezomib sensitize spancreatic cancer cells to endoplasmic reticulum stress mediated apoptosis显示文摘	Nawrocki ST Carew JS Pino MS	2005	Cancer Res2005，65，11：	1
8	Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance显示文摘	Carew JS	2007	Blood2007，110，：	1
9	Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications 显示文摘	Carew JS Zhou Y Albitar M	2003	Leukemia2003，17，8：	1
10	Aggresome disruption:a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells显示文摘	Nawrocki ST Carew JS Pino MS	2006	Cancer Res2006，66，7：	1
11	Histone deacetylase inhibitors:Mechanisms of cell death and promise in combination cancer therapy显示文摘	Carew JS Giles FJ Nawrocki ST	2008	Cancer Lett2008，269，1：	1
12	Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy 显示文摘	Carew JS Giles FJ Nawrocki ST	2008	Cancer Lett2008，269，1：	1
13	Mechanisms of mTOR inhibitor resistance in cancer therapy显示文摘	Carew JS Kelly KR Nawroeki ST	2011	Target Oncol2011，6，：	1
14	Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells 显示文摘	Nawrockj ST Carew JS Dunner K	2005	Cancer Res2005，65，11：	1
15	Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy 显示文摘	Carew JS Giles FJ Nawrocki ST	2008	Cancer Lett2008，269，1：	1
16	Targeting survivin inhibits renal cell carcinoma progression and enhances the activity of tem- sirolimus 显示文摘	Carew JS Espitia CM Zhao W	2015	Molecular cancer therapeutics2015，9，1：	1
17	Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance显示文摘	Carew JS Nawrocki ST Kahue CN	2007	Blood2007，110，1：	1
18	Targeting HSP90 for cancer therapy显示文摘	Mahalingam D Swords R Carew JS	2009	Br J Cancer2009，100，10：	1
19	Increased mitochon- drial biogenesis in primary leukemia cells: the role of en- dogenous nitric oxide and impact on sensitivity to fludara- bine显示文摘	Carew JS Nawrocki ST Xu RH	2004	Leukemia2004，18，：	1
20	Targeting HSP90 for cancer therpy显示文摘	Mahalingam D Swords R Carew JS	2009	Br J Cancer2009，100，10：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示